Subscribe
Machinery & Materials
Markets
Logistics & Cold Chain
Newsletters
Eli Lilly and Company
More from Eli Lilly and Company
Take Five
Applying Modern Technology to Pharmaceutical Production Facilities
Robotics, biometrics, and isolator technology are proving cleaner, faster, and safer than traditional manual methods.
Regulatory
Applying Modern Technology to Pharmaceutical Production Facilities
Robotics, biometrics, and isolator technology are proving cleaner, faster, and safer than traditional manual methods.
Pharmaceutical
Walmart, Walgreens Join MediLedger to Fight Counterfeit Drugs
The retail behemoths have joined the blockchain pharma supply chain project aimed at tackling the counterfeit drug market.
Pharmaceutical
Brexit Contingency Plans for Pharma Industry
The EU currently supplies two-thirds of the medicines in the UK. How will Brexit affect pharmaceutical investments and manufacturing?
Pharmaceutical
Trump Nominates Alex Azar for HHS Secretary
President Trump picks former Eli Lilly executive to “be a star for better healthcare and lower drug prices!”
Home
Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017
Significant investment in manufacturing diabetes medicines continues with new $85 million commitment in Indianapolis; $5 billion invested in its U.S. operations over the last decade; more favorable tax climate could lead to additional U.S. investments.
Pharmaceutical
Top 10 Patent Cliffs of 2017
Patent expiration is clearing a path for generics to take over; here’s a look at the top 10 patents expiring this year.
Pharmaceutical
Trump to Pharma: Lower Prices & Fewer Regulations
President Trump met with Big Pharma players to discuss lowering prices and bringing drug manufacturing back to the U.S.
Home
Eli Lilly compliance pack earns honors
The 2014 HCPC Compliance Package of the Year First Runner Up was awarded to the Eli Lilly Strattera® Physician Sample Pack from PCI, which contains medication for the treatment of attention-deficit/hyperactivity disorder (ADHD).
